Chen Z, Chen S J, Tong J H, Zhu Y J, Huang M E, Wang W C, Wu Y, Sun G L, Wang Z Y, Larsen C J
Department of Hematology, Shanghai Rui Jin Hospital, Shanghai Second Medical University, China.
Leukemia. 1991 Apr;5(4):288-92.
The t(15;17)(q22;q11-q21) translocation, a hallmark for acute promyelocytic leukemia (APL), has recently been shown to disrupt the retinoic acid-alpha receptor (RARA) gene localized on band 17q21. Leukemic cell DNAs from 16 Chinese patients with APL were analysed by Southern blot hybridization with probes covering the 5' and the 3' parts of the gene. In ten patients, the breakpoints were concentrated within a 5.5 kb EcoRI fragment containing part of intron 1, whereas no rearrangement was detected in the six remaining patients. Genomic amplification of the RARA gene was observed in one case. When RNA was available (six patients), abnormal-sized RARA gene transcripts were observed. Interestingly, no rearranged transcript was found in cells from a patient during a 6-day treatment with all-trans retinoic acid, while bone marrow cells still possessed the translocation.
t(15;17)(q22;q11-q21)易位是急性早幼粒细胞白血病(APL)的一个标志,最近研究表明该易位会破坏位于17q21带的维甲酸-α受体(RARA)基因。用覆盖该基因5'和3'部分的探针,通过Southern印迹杂交分析了16例中国APL患者的白血病细胞DNA。10例患者的断点集中在一个包含第1内含子部分的5.5kb EcoRI片段内,而其余6例患者未检测到重排。1例患者观察到RARA基因的基因组扩增。当有RNA可用时(6例患者),观察到异常大小的RARA基因转录本。有趣的是,在一名患者接受全反式维甲酸治疗6天期间,细胞中未发现重排转录本,而骨髓细胞仍存在该易位。